Genetic mutations play a crucial role in the development and progression of cancer. Identifying specific mutations, such as those in the BRCA1 and BRCA2 genes, can help in determining the best course of treatment. For example, patients with BRCA mutations may benefit from PARP inhibitors, a type of targeted therapy.
